Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies | Zendy

Xavier Guirao | Zendy; Miguel Sánchez García | Zendy; Matteo Bassetti | Zendy; K. F. Bodmann | Zendy; Hervé Dupont | Zendy; Philippe Montravers | Zendy; W. R. Heizmann | Zendy; Maria Rita Capparella | Zendy; D. Simoneau | Zendy; Christian Eckmann | Zendy

Open Access

Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies

Author(s) -

Xavier Guirao,

Miguel Sánchez García,

Matteo Bassetti,

K. F. Bodmann,

Hervé Dupont,

Philippe Montravers,

W. R. Heizmann,

Maria Rita Capparella,

D. Simoneau,

Christian Eckmann

Publication year - 2013

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt143

Subject(s) - tolerability , tigecycline , medicine , nausea , observational study , vomiting , adverse effect , intensive care , comorbidity , surgery , intensive care medicine , antibiotics , biology , microbiology and biotechnology

Tigecycline is approved for the treatment of complicated skin and soft-tissue infections (cSSTIs) and complicated intra-abdominal infections (cIAIs) in adults. In this analysis the safety and tolerability profile of tigecycline (used alone or in combination) for the treatment of patients with approved indications of cSSTI and cIAI were examined under real-life clinical conditions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research